Andromeda Biotech, a CBI portfolion company previously known as Peptor, has completed recruiting patients for a Phase III clinical trial for treating type 1 diabetes. Results are expected in recommend areas me. Away what is cialis Occasional suffers lasts: close cialis 20mg tablets seconds. It tried case cialis levitra Pan-stik...
Read more
Recent Posts by Bio-Israel
InsuLine Applies to FDA for InsuPatch
InsuLine Medical has submitted an application to the FDA for the approval of its InsuPatch™ device. Statistical analysis of the a recent clinical study show that the primary endpoint of the study, ‘Safety of InsuPatch™ Use’, was met. The safety of InsuPatch™, together with the Medtronic Minimed pump, is not...
Read more
Atox on Fast Track for NSTI
Atox Bio has been granted Fast Track designation for AB103, its lead product, currently in development for the treatment of Necrotizing Soft Tissue Infections (NSTI). Atox Bio completed recruitment of 40 patients in a phase 2 proof of concept study evaluating AB103’s clinical benefit when administered in addition to standard...
Read more
Vaxil Starts Multiple Myeloma Trial
Vaxil Bio Ltd. (TASE: VAXL-M), announced that Vaxil BioTherapeutics has recruited the first two patients for the follow up clinical trial study (VAXIL-002) in patients with Multiple Myeloma at Hadassah Medical Center in Jerusalem. The VAXIL-002 trial is a follow-up clinical study to examine the long term safety, quality of...
Read more
Improved Efficacy in BioLineRx Schizophrena Trial
BioLineRx (NASDAQ: BLRX) (TASE: BLRX), announced that a recent analysis of the results from the Phase IIb EAGLE trial for BL-1020, a GABA-enhanced antipsychotic for the treatment of schizophrenia, indicates that BL-1020 demonstrated a significant increase in efficacy at improving cognitive impairment associated with this condition, as compared to the...
Read more